Fuji Pharma Co Ltd
TSE:4554
Fuji Pharma Co Ltd
Current Portion of Long-Term Debt
Fuji Pharma Co Ltd
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fuji Pharma Co Ltd
TSE:4554
|
Current Portion of Long-Term Debt
¥3.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
8%
|
CAGR 10-Years
15%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Current Portion of Long-Term Debt
¥367.3B
|
CAGR 3-Years
155%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
9%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Current Portion of Long-Term Debt
¥399m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
-45%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Current Portion of Long-Term Debt
¥72B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
32%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Current Portion of Long-Term Debt
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Astellas Pharma Inc
TSE:4503
|
Current Portion of Long-Term Debt
¥472.3B
|
CAGR 3-Years
208%
|
CAGR 5-Years
306%
|
CAGR 10-Years
84%
|
See Also
What is Fuji Pharma Co Ltd's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
3.6B
JPY
Based on the financial report for Dec 31, 2023, Fuji Pharma Co Ltd's Current Portion of Long-Term Debt amounts to 3.6B JPY.
What is Fuji Pharma Co Ltd's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
15%
Over the last year, the Current Portion of Long-Term Debt growth was 4%. The average annual Current Portion of Long-Term Debt growth rates for Fuji Pharma Co Ltd have been 19% over the past three years , 8% over the past five years , and 15% over the past ten years .